Sarcoidosis differential diagnosis

Revision as of 15:33, 10 May 2018 by Roshan (talk | contribs)
Jump to navigation Jump to search

Sarcoidosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Sarcoidosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Sarcoidosis differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Sarcoidosis differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Sarcoidosis differential diagnosis

CDC on Sarcoidosis differential diagnosis

Sarcoidosis differential diagnosis in the news

Blogs on Sarcoidosis differential diagnosis

Directions to Hospitals Treating Sarcoidosis

Risk calculators and risk factors for Sarcoidosis differential diagnosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Roshan Dinparasti Saleh M.D.

Overview

Sarcoidosis has many differentials, which can be classified depending on the organ involved, pathologic findings and laboratory findings.

Differential Diagnosis

Sarcoidosis has been defined as a multisystem granulomatous disorder of unknown cause[1], but granulomatous inflammation alone is not sufficient for the diagnosis of sarcoidosis because alternative etiologies of granulomatous inflammation need to be excluded.

Causes of granulomatous reaction beside sarcoidosis

Data supporting the likelihood of sarcoidosis

  1. Demographics
    1. U.S. African American
    2. Northern European
  2. Medical history
    1. Non-smoker
    2. No symptoms(in patient with bilateral hilar adenopathy on CXR)
    3. Family history of sarcoidosis
    4. Symptoms involving more than two organs commonly involved by sarcoidosis
  3. Laboratory data
    1. Elevated ACE level (especially if > 2× ULN)
    2. Elevated calcium level
    3. Elevated alkaline phosphatase level
    4. Elevated soluble IL-2 receptor
    5. Leukopenia
  4. Radiographic findings
    1. CXR:
      1. bilateral hilar adenopathy especially if without symptoms)
      2. Upper lobe disease
    2. HRCT:
      1. Disease along bronchovascular bundle
      2. Subpleural reticulonodular infiltrates
      3. Mediastinal adenopathy
      4. Peribronchial thickening
      5. Traction bronchiectasis of upper lobe
  5. Skin lesions
    1. Lupus pernio
    2. Erythema nodosum
    3. Maculopapular lesions
  6. Ocular disease
    1. Uveitis
    2. Optic neuritis
  7. Neurological disease
    1. Seventh cranial nerve palsy
  8. Renal disease
    1. Nephrocalcinosis
    2. Interstitial nephritis[2]

Data weakening the likelihood of sarcoidosis

  1. Demographics
    1. Age< 18 years
  1. Medical history
    1. Exposure to tuberculosis
    2. Exposure to organic bioaerosol
    3. Exposure to beryllium
    4. Intravenous drug abuse
  1. Laboratory data
    1. Positive anti-neutrophil cytoplasm antibody (ANCA)
  1. Radiographic findings
    1. CXR:
      1. Pleural effusion
    2. HRCT:
      1. Subpleural honeycombing
  1. Ocular disease
    1. Episcleritis
  1. Renal disease
    1. Glumerulonephritis [2]






References

  1. 1.0 1.1 Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 160:736–755, 1999.
  2. 2.0 2.1 Judson MA: The diagnosis of sarcoidosis. Clin Chest Med 29(3):415–427, 2008.